AKEBIA THERAPEUTICS, INC. Operating Leases, Rent Expense
AKEBIA THERAPEUTICS, INC. (AKBA) reported Operating Leases, Rent Expense of $3.70 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-02-25
- AKEBIA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2018-12-31 was $1.30M, a 62.50% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2018-09-30 was $800.00K, a 0.00% change year-over-year.
- AKEBIA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2018-06-30 was $800.00K, a 0.00% change year-over-year.
- AKEBIA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2018-03-31 was $800.00K, a 0.00% change year-over-year.
- AKEBIA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2018 was $3.70M, a 15.63% increase from fiscal 2017.
- AKEBIA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2017 was $3.20M, a 28.00% increase from fiscal 2016.
- AKEBIA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2016 was $2.50M, a 177.78% increase from fiscal 2015.
- AKEBIA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2015 was $900.00K, a 125.00% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.10M derived: sum of 2 quarters · filed 2021-02-25 | $2.90M derived: sum of 3 quarters · filed 2021-02-25 | $3.70M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $800.00K 10-Q · filed 2018-11-08 | $1.60M derived: sum of 2 quarters · filed 2018-11-08 | $2.40M 10-Q · filed 2018-11-08 | $3.20M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | $800.00K 10-Q · filed 2018-08-08 | $1.60M 10-Q · filed 2018-08-08 | $2.40M derived: sum of 3 quarters · filed 2020-03-12 | $3.20M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | $800.00K 10-Q · filed 2018-05-09 | $1.60M derived: sum of 2 quarters · filed 2020-03-12 | $2.40M derived: sum of 3 quarters · filed 2020-03-12 | $3.20M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.60M derived: sum of 2 quarters · filed 2020-03-12 | $2.40M derived: sum of 3 quarters · filed 2020-03-12 | $3.20M 10-K · filed 2020-03-12 | |||
| 2017-09-30 | $800.00K 10-Q · filed 2018-11-08 | $1.60M derived: sum of 2 quarters · filed 2018-11-08 | $2.40M 10-Q · filed 2018-11-08 | $3.20M derived: sum of 4 quarters · filed 2019-03-26 | |||
| 2017-06-30 | $800.00K 10-Q · filed 2018-08-08 | $1.60M 10-Q · filed 2018-08-08 | $2.40M derived: sum of 3 quarters · filed 2019-03-26 | $3.00M derived: sum of 4 quarters · filed 2019-03-26 | |||
| 2017-03-31 | $800.00K 10-Q · filed 2018-05-09 | $1.60M derived: sum of 2 quarters · filed 2019-03-26 | $2.20M derived: sum of 3 quarters · filed 2019-03-26 | $2.90M derived: sum of 4 quarters · filed 2019-03-26 | |||
| 2016-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $1.40M derived: sum of 2 quarters · filed 2019-03-26 | $2.10M derived: sum of 3 quarters · filed 2019-03-26 | $2.50M 10-K · filed 2019-03-26 | |||
| 2016-09-30 | $600.00K 10-Q · filed 2017-11-08 | $1.30M derived: sum of 2 quarters · filed 2017-11-08 | $1.70M 10-Q · filed 2017-11-08 | $2.00M derived: sum of 4 quarters · filed 2017-11-08 | |||
| 2016-06-30 | $700.00K 10-Q · filed 2017-08-08 | $1.00M 10-Q · filed 2017-08-08 | $1.40M derived: sum of 3 quarters · filed 2017-08-08 | $1.60M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-03-31 | $400.00K 10-Q · filed 2017-05-09 | $700.00K derived: sum of 2 quarters · filed 2017-05-09 | $900.00K derived: sum of 3 quarters · filed 2017-05-09 | $1.10M derived: sum of 4 quarters · filed 2017-05-09 | |||
| 2015-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $500.00K derived: sum of 2 quarters · filed 2017-03-06 | $700.00K derived: sum of 3 quarters · filed 2017-03-06 | $900.00K 10-K · filed 2017-03-06 | |||
| 2015-09-30 | $200.00K 10-Q · filed 2016-11-09 | $400.00K derived: sum of 2 quarters · filed 2016-11-09 | $600.00K 10-Q · filed 2016-11-09 | $600.00K derived: sum of 4 quarters · filed 2016-11-09 | |||
| 2015-06-30 | $200.00K 10-Q · filed 2016-08-08 | $400.00K 10-Q · filed 2016-08-08 | $300.00K 10-Q · filed 2015-08-11 | $400.00K derived: sum of 3 quarters · filed 2016-08-08 | $500.00K derived: sum of 4 quarters · filed 2016-08-08 | ||
| 2015-03-31 | $100.00K 10-Q · filed 2016-05-05 | $122.00K 10-Q · filed 2015-05-11 | $200.00K derived: sum of 2 quarters · filed 2016-05-05 | $300.00K derived: sum of 3 quarters · filed 2016-05-05 | $400.00K derived: sum of 4 quarters · filed 2016-05-05 | ||
| 2014-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $200.00K derived: sum of 2 quarters · filed 2016-03-14 | $300.00K derived: sum of 3 quarters · filed 2016-03-14 | $400.00K 10-K · filed 2016-03-14 | $377.58K 10-K · filed 2015-03-04 | ||
| 2014-09-30 | $100.00K 10-Q · filed 2015-11-09 | $200.00K derived: sum of 2 quarters · filed 2015-11-09 | $300.00K 10-Q · filed 2015-11-09 | ||||
| 2014-06-30 | $100.00K 10-Q · filed 2015-08-11 | $200.00K 10-Q · filed 2015-08-11 | |||||
| 2014-03-31 | $98.00K 10-Q · filed 2015-05-11 | ||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |